A Comparative Analysis of the BRAZPD Data With the Spanish Dialysis Guidelines: Successes and Failures

Introduction: One aim of evidence based learning is to establish guidelines to reach goals obtained from clinical evidences. Reconciliation of guidelines is desired, however, adaptations should be made for the reality of each country. AIM: To assess the degree of adherence to the therapeutic recommendations proposed by the Spanish dialysis guidelines in a cohort of Brazilian patients on peritoneal dialysis (PD). Patients and Methods: A descriptive, cross-sectional study was performed in prevalent and incident patients on PD (BRAZPD) enrolled between December of 2004 and February of 2007, and followed for >3 months. Demographic, clinical and laboratorial data were assessed using electronic medical records. Results : A total of 3,226 patients were assessed, 2,094 of them were incident, observed for a mean time of 13.6 months. The mean age was 54±19 years (34% were over 65 years), 55% were female, and 64% were white. The main etiology of CKD was diabetic nephropathy (34%), 13% were illiterate, 57% had basic education and 42% of the patients had an income of two minimum wages. Compared to the Spanish guidelines, our patients were older, diabetic, and presented larger number of comorbidities (higher David score). The prevalence of infectious complications was low and there was a good fulfillment of recommended lab targets, with the exception of hemoglobin levels. The survival rates at 26 month were 72% and 75% for incident and prevalent patients, respectively. Conclusion : The standards of care of PD delivered to the patients of BRAZPD are in agreement with those recommended internationally.

[1]  R. Pecoits-Filho,et al.  The Brazilian Peritoneal Dialysis Multicenter Study (BRAZPD) : characterization of the cohort. , 2008, Kidney international. Supplement.

[2]  P. Bossuyt,et al.  Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  E. Bedrick,et al.  Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization? , 2007, Journal of the American Society of Nephrology : JASN.

[4]  G. Eknoyan,et al.  The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. , 2007, Kidney international.

[5]  R. Sesso,et al.  Overview of Peritoneal Dialysis in Latin America , 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[6]  A. Wang,et al.  The “Heart” of Peritoneal Dialysis: Residual Renal Function , 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[7]  J. Bargman,et al.  K/DOQI guideline requirements for calcium, phosphate, calcium phosphate product, and parathyroid hormone control in dialysis patients: can we achieve them? , 2007, International Urology and Nephrology.

[8]  N. Powe,et al.  Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study , 2007, BMC Health Services Research.

[9]  S. Mujais,et al.  Peritoneal dialysis in the US: evaluation of outcomes in contemporary cohorts. , 2006, Kidney international. Supplement.

[10]  A. Cheung,et al.  The association of lipid levels with mortality in patients on chronic peritoneal dialysis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  M. Lam,et al.  ASPD: A Prospective Study of Adequacy in Asian Patients on Long Term, Small Volume, Continuous Ambulatory Peritoneal Dialysis , 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[12]  Kdoqi Disclaimer,et al.  KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  E. D. de Faria,et al.  The use of a hospital laboratory cohort to estimate the prevalence of dyslipidemia in an adult Brazilian population. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[14]  G. García-García,et al.  Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (REDTJAL). , 2005, Kidney international. Supplement.

[15]  B. C. Kwan,et al.  Hypokalemia in Chinese peritoneal dialysis patients: prevalence and prognostic implication. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  C. Combe,et al.  Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  R. Foley,et al.  Anemia, hospitalization, and mortality in patients receiving peritoneal dialysis in the United States. , 2004, Kidney international.

[18]  A. Peixoto,et al.  Methods of Assessment of Volume Status and Intercompartmental Fluid Shifts in Hemodialysis Patients: Implications in Clinical Practice , 2004, Seminars in dialysis.

[19]  L. D. de Souza,et al.  Prevalence of dyslipidemia and risk factors in Campos dos Goytacazes, in the Brazilian state of Rio de Janeiro. , 2003, Arquivos brasileiros de cardiologia.

[20]  P. Blake,et al.  Changes in Peritoneal Dialysis Practices in Canada 1996 – 1999 , 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[21]  G. Russ,et al.  ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  R. Krediet The rise and fall of the K(t)/V concept in CAPD. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  S. Davies,et al.  Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  F. Dekker,et al.  When to initiate dialysis: effect of proposed US guidelines on survival , 2001, The Lancet.

[25]  D. Oreopoulos,et al.  Chronic Peritoneal Dialysis in the Elderly: A Review , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[26]  F. Dekker,et al.  Dialysis in The Netherlands: the clinical condition of new patients put into a European perspective. NECOSAD Study Group. Netherlands Cooperative Study on the Adequacy of Dialysis phase 1. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  D. Churchill,et al.  Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. , 1997, Journal of the American Society of Nephrology : JASN.

[28]  B. Atasever,et al.  Analysis of Ultrafiltration Failure in Peritoneal Dialysis Patients by Means of Standard Peritoneal Permeability Analysis , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[29]  R. Sesso,et al.  Late diagnosis of chronic renal failure and mortality on maintenance dialysis , 1996 .

[30]  G. García-García,et al.  Risk of peritonitis among disadvantaged CAPD patients in Mexico. , 2007, Contributions to nephrology.

[31]  D. Brancaccio,et al.  Calcium and phosphate handling in peritoneal dialysis. , 2006, Contributions to nephrology.

[32]  R. Krediet European best practice guidelines for peritoneal dialysis - Preface; European Best Practice Guideline , 2005 .

[33]  A. Gupta,et al.  Does serum albumin at start of continuous ambulatory peritoneal dialysis (CAPD) or its drop during CAPD determine patient outcome? , 2000, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[34]  Rozana Mesquita Ciconelli,et al.  Tradução para o português e validação do questionário genérico de avaliação de qualidade de vida medical outcomes study 36-item short-form health survey (SF-36) , 1997 .

[35]  Canada-USA (CANUSA) multicentre study of peritoneal dialysis adequacy: description of the study population and preliminary results. CANUSA Peritoneal Dialysis Study Group. , 1992, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[36]  F. Ansfield Present status of clinical cancer chemotherapy. , 1965, Antimicrobial agents and chemotherapy.

[37]  K. Simpson,et al.  Nephrology Dialysis Transplantation Improved Survival in Renal Replacement Therapy in Europe between 1975 and 1992 an Era-edta Registry Study , 2022 .